Factors associated with visual acuity loss after noncontact transscleral Nd:YAG cyclophotocoagulation

Journal of Glaucoma

Volumn 5, Issue 6, 1996, Pages 390-394

  Youn, Jouweon ^a   Cox, Terry A ^a   Allingham, R Rand ^a   Shields, M Bruce ^a  

^a DUKE UNIVERSITY EYE CENTER   (United States)

Author keywords

Black race; Neovascular glaucoma; The factors associated with visual acuity loss; Transscleral Nd:YAG cyclophotocoagulation

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; FEMALE; FILTERING OPERATION; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; LASER COAGULATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEOVASCULAR GLAUCOMA; PRIORITY JOURNAL; RISK; SCHOOL CHILD; VISUAL ACUITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CILIARY BODY; FEMALE; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; LASER COAGULATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS; SCLERA; VISION DISORDERS; VISUAL ACUITY;

EID: 0029855163     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Klapper RM, Wandel T, Donnenfeld E, Perry HD. Transscleral neodymium:YAG thermal cyclophotocoagulation in refractory glaucoma: a preliminary report. Ophthalmology 1988;95:719-22.
2. Trope GE, Ma S. Mid-term effects of neodymium:YAG transscleral cyclophotocoagulation in glaucoma. Ophthalmology 1990;97: 73-5.
3. Hampton C, Shields MB, Miller KN, Blasini M. Evaluation of a protocol for transscleral neodymium:YAG cyclophotocoagulation in one hundred patients. Ophthalmology 1990;97:910-7.
4. Kalenak JW, Parkinson JM, Kass MA, Kolker AE. Transscleral neodymium:YAG laser cyclophotocoagulation for uncontrolled glaucoma. Ophthalmic Surg 1990;21:346-51.
5. Crymes BM, Gross RL. Laser placement in noncontact Nd:YAG cyclophotocoagulation. Am J Ophthalmol 1990;110:670-3.
6. Simmons RB, Shields MB, Blasini M, et al. Transscleral Nd:YAG laser cyclophotocoagulation with a contact lens. Am J Ophthalmol 1991;112:671-7.
7. Wright MA, Grajewski AL, Feuer WJ. Nd:YAG cyclophotocoagulation: outcome of treatment for uncontrolled glaucoma. Ophthalmic Surg 1991;22:279-83.
8. Balazsi G. Noncontact thermal mode Nd:YAG laser cyclophotocoagulation in the treatment of glaucoma: intermediate follow-up. Ophthalmology 1991;98:1858-63.
9. Hosmer DW, Lemeshow S. Applied logistic regression. New York: Wiley, 1989:140-5.
10. Shields MB, Wilkerson M, Echelman DA. A comparison of two energy levels for noncontact transscleral neodymium:YAG cyclophotocoagulation. Arch Ophthalmol 1993;111:484-7.
11. Shields MB, Shields SE. Noncontact transscleral Nd:YAG cyclophotocoagulation: a long-term follow-up of 500 patients. Trans Am Ophthalmol Soc 1994;XCII:271-87.
12. Caprioli J, Strang SL, Spaeth GL, Poryzees EH. Cyclocryotherapy in the treatment of advanced glaucoma. Ophthalmology 1985;92: 947-54.
13. Brindley O, Shields MB. Value and limitations of cyclocryotherapy. Graefes Arch Clin Exp Ophthalmol 1986;224:545-8.
14. Schuman JS, Bellows AR, Shingleton BJ, et al. Contact transscleral Nd:YAG laser cyclophotocoaeulation: mid-term results. Ophthalmology 1992;99:1089-95.
15. Weinreb RN. Adjusting the dose of 5-fluorouracil after filtration surgery to minimize side effects. Ophthalmology 1987;94:564-70.
16. Heuer DK, Parrish PK II, Gressel MG, et al. 5-fluorouracil and glaucoma filtering surgery. Ophthalmology 1984;91:384-94.
17. Sutton GE, Popp JC, Records RE. Krupin-Denver valve and neovascular glaucoma. Trans Ophthalmol Soc UK 1982;102:119-21.
18. Krupin T, Kaufman P, Mandell AI, et al. Long-term results of valve implants in filtering surgery for eyes with neovascular glaucoma. Am J Ophthalmol 1983;95:775-82.